Five markets. Five data points. A 10.8% to 38.4% discount. That’s the headline from the joint letter submitted by the Hyperliquid Policy Center (HPC) and trade[XYZ] to the SEC on August 19. They claim their new product—the Initial Perpetual Offering Program (IPOP)—exposes systematic IPO underpricing. Sounds like a smoking gun for market inefficiency. But who’s holding the gun? The same people who built the product, ran the markets, and now want the SEC to bless it. I’ve spent enough time in the trenches to know that when the inventor brings the data, the numbers are shaped to fit the narrative. Code doesn’t lie, but people do.
Let me be clear: I’m not dismissing the idea of pre-IPO price discovery. I’ve seen the chaos around IPO allocations, the gray market spreads, the insider advantages. A synthetic perpetual that tracks an upcoming listing could be a tool for the retail trader who wants a piece of the action before the bell rings. But the way this is being sold—as a regulatory innovation that proves IPO efficiency—smells like a PR play dressed in technical clothing. I audit the logic, not the hope.
Context: What Is IPOP, Really?
IPOP is a synthetic perpetual swap that settles at the IPO price or the first-day open. Traders can go long or short a company before it lists. No equity, no voting rights, no allocation. Just a cash-settled derivative that terminates when the stock starts trading. The product runs on Hyperliquid’s order book, which is itself a high-throughput DeFi exchange built on a custom L1.
The HPC letter claims that IPOP addresses a core problem: IPOs are priced too low, leaving money on the table for underwriters and insiders, while retail gets crumbs. They cite five completed IPOP markets—each one showing that the IPO price was below the IPOP price on the day before listing. The discount range: 10.8% to 38.4%. On the surface, that’s a compelling argument for better price discovery. But surface-level data is the first thing I learned to distrust.
Core: The Data That Doesn’t Add Up
I’ve audited smart contracts for a living. I’ve pulled raw transaction data from Etherscan to verify claims. The first rule: if the data source is also the product developer, treat it as a hypothesis, not a conclusion.
The HPC letter is authored by trade[XYZ]—likely the same entity that is the primary market maker and liquidity provider for these IPOP markets. They are not an independent auditor. They are not a neutral academic institution. They are a counterparty with a direct financial interest in seeing IPOP gain regulatory approval. The 10.8%–38.4% discount is a data point they chose to present. What about the markets that didn’t work? What about the ones where the IPOP price diverged from the eventual IPO price due to low liquidity? The letter doesn’t say.
Five markets is a statistically insignificant sample. In crypto, we’ve seen products with thousands of trades still fail to provide accurate price discovery—look at the chaos in prediction markets during the 2020 election. The sample size problem is compounded by the fact that these IPOP markets likely had low open interest and thin order books. I’ve seen flash loan arbitrage execute on $10,000 pools with less slippage than some of these IPOPs probably experienced.
More critically, the settlement mechanism is not disclosed. How is the final price determined? Is it the IPO price, the first trade price, a volume-weighted average of the first hour? The letter is silent. In traditional derivatives, the settlement source is a critical design decision—it determines whether the product can be manipulated. If the settlement relies on a single oracle or a centralized data feed, then the entire IPOP market is vulnerable to the same kind of manipulation that plagues many DeFi protocols. I’ve seen this firsthand: in 2021, I was auditing a yield aggregator that used a TWAP oracle from a single DEX. The moment a whale moved, the oracle lagged, and the arbitrage bots drained the pool.
The HPC letter also claims that IPOP markets accurately reflected the eventual IPO price. But "accurately" is a loaded term. A 10% discount on the day before listing could mean the market was pricing in risk, or it could mean the market was illiquid and the last trade was a fluke. Without order book depth, trade frequency, and bid-ask spread data, the claim is meaningless.
Technical Gaps That Keep Me Up at Night
Let’s talk about the liquidation engine. IPOPs are perpetuals, which means they have funding rates, margin requirements, and liquidation cascades. The letter doesn’t mention how these parameters are set. If the product is meant to mimic a stock, then the funding rate should reflect the cost of carry, but what is the "cost of carry" for a company that hasn’t listed? It’s a black box.
There is also no disclosure of the collateral model. Is it USDC, HYPE, or a basket of assets? If it’s HYPE, then the risk is circular: the value of the collateral depends on the health of the exchange, which itself depends on the success of products like IPOP. That’s a correlation risk I’ve seen destroy portfolios. During the Terra collapse, I lost 40% of my portfolio because I was holding UST as collateral for a yield farm. The moment the peg broke, the liquidation engine couldn’t keep up. I learned that day: if the collateral is correlated with the protocol, you’re not hedging; you’re levering.
The risk of insider trading is the elephant in the room. An IPOP market for a company that has not yet filed an S-1 is a playground for anyone with access to non-public information. The SEC is already cracking down on insider trading in crypto. The HPC letter tries to preempt this by suggesting that IPOPs can improve market integrity, but it’s a weak argument. The product is designed to allow anonymous trading on a pseudonymous blockchain. The KYC status is not mentioned. The letter asks for "clarity" on investor accessibility, which is a polite way of saying they want to operate without full compliance.
Contrarian: The Real Play Is Regulatory Arbitrage, Not Price Discovery
The mainstream narrative will be: "Hyperliquid is pioneering a new asset class that makes IPOs fairer." I’m not buying it. The real story is that trade[XYZ] and HPC are trying to get a regulatory foothold before the SEC defines the rules. They are framing IPOPs as a public good—price discovery for the masses—to avoid being classified as a security-based swap.
If the SEC treats IPOPs as swaps, they fall under the CFTC’s jurisdiction. If they are considered securities, the SEC requires full registration, disclosure, and investor protections. The HPC letter is a preemptive strike: "Look, we’re already helping the market. Don’t shut us down."
This is not a breakthrough in financial engineering. It’s a regulatory gamble. The five IPOP markets were likely run on a small scale, with non-US users, to build a case for legitimacy. The data is cherry-picked to show the best possible outcome. I’ve seen this pattern before: in 2023, I audited an AI trading bot that claimed 30% monthly returns. The backtest showed a perfect curve. But when I checked the API logs, I found that the bot was only executing trades during low-volatility periods and ignoring fees. The "profit" was an artifact of selection bias.
The same applies here. The 10.8%–38.4% discount is the best case. What about the IPOP market that failed to settle correctly? What about the ones where the price diverged due to a whale dumping? The letter doesn’t say.
Takeaway: Actions, Not Narratives
The SEC will likely not respond quickly. They have bigger fish to fry. But the market will react regardless. Here’s what I’m watching:
First, the settlement oracle. If HPC discloses a transparent, decentralized oracle for IPOP settlement, I’ll increase my confidence. If they keep it vague, assume the product is a toy.
Second, the order book depth. I want to see the bid-ask spread and volume for the next IPOP market. If it’s a few hundred dollars, the price discovery claim is laughable.
Third, the regulatory response. If the SEC issues a no-action letter, the product gains legitimacy. But if they issue a Wells notice, trade[XYZ] will be in trouble.
I’m not trading IPOPs until I see the settlement code. I don’t trust the narrative; I trust the stack. Trust the stack, verify the exit.
The HPC letter is a well-written piece of advocacy. But advocacy is not evidence. The 10.8%–38.4% discount is interesting, but it’s a single data point from a biased source. In crypto, the difference between a protocol and a scam is often just the depth of the audit. Here, there is no audit. There is only a letter.
And in this market, where euphoria masks technical flaws, the letter is exactly the kind of story that retail traders will buy. But I’ve been burned before. I’ve seen the Terra collapse, the FTX fraud, the EigenLayer complexity. Each time, the narrative was beautiful. Each time, the code was messy.
So I’ll pass on the IPOP hype. I’ll wait for the SEC response. I’ll check the oracle. I’ll verify the exit. And if the product delivers, I’ll be happy to trade it. But until then, I’m watching from the sidelines.
Arbitrage is just patience wearing a speed suit. And I’m patient enough to let this one play out.